|
[1]SIEGEL RL, MILLER KD, JEMAL A.Cancer statistics, 2019[J].CA Cancer J Clin, 2019, 69 (1) :7-34.
|
|
[2]CHEN W, ZHENG R, BAADE PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2) :115-132.
|
|
[3] KAMISAWA T, WOOD LD, ITOI T, et al.Pancreatic cancer[J].Lancet, 2016, 388 (10039) :73-85.
|
|
[4] ZHAO YP.Importance of the multidisciplinary diagnosis and treatment of pancreatic cancer[J].Chin J Surg, 2016, 54 (11) :801-803. (in Chinese) 赵玉沛.重视胰腺癌的多学科诊疗[J].中华外科杂志, 2016, 54 (11) :801-803.
|
|
[5]DESAI NV, SLIESORAITIS S, HUGHES SJ, et al.Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer[J].Cancer Med, 2015, 4 (8) :1224-1239.
|
|
[6]COVELER AL, HERMAN JM, SIMEONE DM, et al.Localized pancreatic cancer:Multidisciplinary management[J].Am Soc Clin Oncol Educ Book, 2016, 35:e217-e226.
|
|
[7]RAO B, SYED A, SINGH S, et al.Performance of a multidisciplinary pancreatic cancer conference in predicting and managing resectable pancreatic cancer[J].Pancreas, 2019, 48 (1) :80-84.
|
|
[8]LUO G, LIU C, GUO M, et al.CA19-9-Low&Lewis (+) pancreatic cancer:A unique subtype[J].Cancer Lett, 2017, 385:e217-e226..
|
|
[9]PORUK KE, GAY DZ, BROWN K, et al.The clinical utility of CA19-9 in pancreatic adenocarcinoma:Diagnostic and prognostic updates[J].Curr Mol Med, 2013, 13 (3) :340-351.
|
|
[10] MELO SA, LUECKE LB, KAHLERT C, et al.Glypican-1 identifies cancer exosomes and detects early pancreatic cancer[J].Nature, 2015, 523 (7559) :177-182.
|
|
[11]Society of Pancreatic Cancer, Chinese Anti-cancer Association.Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2018 version) [J].J Clin Hepatol, 2018, 34 (10) :2109-2120. (in Chinese) 中国抗癌协会胰腺癌专业委员会.胰腺癌综合诊治指南 (2018版) [J].临床肝胆病杂志, 2018, 34 (10) :2109-2120.
|
|
[12]RENI M, BALZANO G, ZANON S, et al.Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15) :A randomised, open-label, phase 2-3 trial[J].Lancet Gastroenterol Hepatol, 2018, 3 (6) :413-423.
|
|
[13]TORPHY RJ, FRIEDMAN C, HALPERN A, et al.Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers[J].Ann Surg, 2018.[Epub ahead of print]
|
|
[14]van HILST J, de ROOIJ T, BOSSCHA K, et al.Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2) :A multicentre, patientblinded, randomised controlled phase 2/3 trial[J].Lancet Gastroenterolo Hepatol, 2019, 4 (3) :199-207.
|
|
[15]WANG M, PENG B, LIU J, et al.Practice patterns and perioperative outcomes of laparoscopic pancreaticoduodenectomy in China:A retrospective multicenter analysis of 1029 patients[J].Ann Surg, 2019.[Epub ahead of print]
|
DownLoad: